Alemtuzumab, sold under the brand name Campath among others, is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis.
This medical drug in use ( in several countries - Russia as example) for immune-suppression of kidney and liver transplants, as preparation against transplant rejection.
What kind mechanisms of immune-suppression in use for this preparation?
Could you explain?